Background: Autoimmune mechanisms have important roles in the pathogenesis of alopecia areata (AA).
Objective: This study aimed to evaluate the exact biological and clinical importance of immunogenes in AA patients using bioinformatic methods.
Methods: Five AA scalp gene expression profiles were obtained from the Gene Expression Omnibus database. Differentially-expressed genes (DEGs) between AA and control groups were identified. An immune-related gene diagnostic signature (IRGDS) was established by protein-protein interaction network analysis, least absolute shrinkage and selection operator and logistic regression analysis.
Results: A total of 102 immune-related DEGs were identified. We developed an IRGDS composed of CD8A, CSF1R and CXCL10 for AA molecular pathological assessment and diagnosis (area under the receiver operating characteristic curve [AUC]=0.962). We also validated the diagnostic value of the IRGDS in an external cohort (AUC=0.955). Patients with high IRGDS scores presented with a higher abundance of immune cell infiltration and expression of genes associated with immune recruitment and immune activation, suggesting adverse biological alterations.
Conclusion: In our study, an IRGDS model with accurately diagnostic capacity for AA was established, and biological alterations were deciphered in AA. The IRGDS may be used as an auxiliary diagnostic marker for AA.
{"title":"Identification of a Novel Three-immunogene Diagnostic Signature for Alopecia Areata.","authors":"Xiuwen Chen, Wenzi Liang, Changmin Lin, Yike Lin","doi":"10.5021/ad.24.053","DOIUrl":"10.5021/ad.24.053","url":null,"abstract":"<p><strong>Background: </strong>Autoimmune mechanisms have important roles in the pathogenesis of alopecia areata (AA).</p><p><strong>Objective: </strong>This study aimed to evaluate the exact biological and clinical importance of immunogenes in AA patients using bioinformatic methods.</p><p><strong>Methods: </strong>Five AA scalp gene expression profiles were obtained from the Gene Expression Omnibus database. Differentially-expressed genes (DEGs) between AA and control groups were identified. An immune-related gene diagnostic signature (IRGDS) was established by protein-protein interaction network analysis, least absolute shrinkage and selection operator and logistic regression analysis.</p><p><strong>Results: </strong>A total of 102 immune-related DEGs were identified. We developed an IRGDS composed of CD8A, CSF1R and CXCL10 for AA molecular pathological assessment and diagnosis (area under the receiver operating characteristic curve [AUC]=0.962). We also validated the diagnostic value of the IRGDS in an external cohort (AUC=0.955). Patients with high IRGDS scores presented with a higher abundance of immune cell infiltration and expression of genes associated with immune recruitment and immune activation, suggesting adverse biological alterations.</p><p><strong>Conclusion: </strong>In our study, an IRGDS model with accurately diagnostic capacity for AA was established, and biological alterations were deciphered in AA. The IRGDS may be used as an auxiliary diagnostic marker for AA.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"37 1","pages":"22-31"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791023/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ji Hyun Lee, Sul Hee Lee, Youin Bae, Young Bok Lee, Yong Hyun Jang, Jiyoung Ahn, Joo Yeon Ko, Hyun-Chang Ko, Hye One Kim, Chan Ho Na, Young-Joon Seo, Min Kyung Shin, Yu Ri Woo, Bark Lyn Lew, Dong Hun Lee, Sang Eun Lee, Jiehyun Jeon, Sun Young Choi, Tae Young Han, Yang Won Lee, Sang Wook Son, Young Lip Park
Background: In 2006, the Korean Atopic Dermatitis Association (KADA) working group released the diagnostic criteria for Korean atopic dermatitis (AD). Recently, more simplified, and practical AD diagnostic criteria have been proposed.
Objective: Based on updated criteria and experience, we studied to develop and share a consensus on diagnostic criteria for AD in Koreans.
Materials and methods: For the diagnostic criteria, a questionnaire was constructed by searching the English-language literature in MEDLINE and the Cochrane Database of Systematic Reviews. A modified Delphi method composed of 3 rounds of email questionnaires was adopted for the consensus process. Fifty-four KADA council members participated in the 3 rounds of votes and expert consensus recommendations were established.
Results: Diagnostic criteria for AD include pruritus, eczema with age-specific pattern, and chronic or relapsing history. Diagnostic aids for AD encompass xerosis, immunoglobulin E reactivity, hand-foot eczema, periorbital changes, periauricular changes, perioral changes, nipple eczema, perifollicular accentuation, and personal or family history of atopy.
Conclusion: This study streamlined and updated the diagnostic criteria for AD in Korea, making them more practicable for use in real-world clinical field.
{"title":"2023 Consensus Korean Diagnostic Criteria for Atopic Dermatitis.","authors":"Ji Hyun Lee, Sul Hee Lee, Youin Bae, Young Bok Lee, Yong Hyun Jang, Jiyoung Ahn, Joo Yeon Ko, Hyun-Chang Ko, Hye One Kim, Chan Ho Na, Young-Joon Seo, Min Kyung Shin, Yu Ri Woo, Bark Lyn Lew, Dong Hun Lee, Sang Eun Lee, Jiehyun Jeon, Sun Young Choi, Tae Young Han, Yang Won Lee, Sang Wook Son, Young Lip Park","doi":"10.5021/ad.24.049","DOIUrl":"10.5021/ad.24.049","url":null,"abstract":"<p><strong>Background: </strong>In 2006, the Korean Atopic Dermatitis Association (KADA) working group released the diagnostic criteria for Korean atopic dermatitis (AD). Recently, more simplified, and practical AD diagnostic criteria have been proposed.</p><p><strong>Objective: </strong>Based on updated criteria and experience, we studied to develop and share a consensus on diagnostic criteria for AD in Koreans.</p><p><strong>Materials and methods: </strong>For the diagnostic criteria, a questionnaire was constructed by searching the English-language literature in MEDLINE and the Cochrane Database of Systematic Reviews. A modified Delphi method composed of 3 rounds of email questionnaires was adopted for the consensus process. Fifty-four KADA council members participated in the 3 rounds of votes and expert consensus recommendations were established.</p><p><strong>Results: </strong>Diagnostic criteria for AD include pruritus, eczema with age-specific pattern, and chronic or relapsing history. Diagnostic aids for AD encompass xerosis, immunoglobulin E reactivity, hand-foot eczema, periorbital changes, periauricular changes, perioral changes, nipple eczema, perifollicular accentuation, and personal or family history of atopy.</p><p><strong>Conclusion: </strong>This study streamlined and updated the diagnostic criteria for AD in Korea, making them more practicable for use in real-world clinical field.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"37 1","pages":"12-21"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791022/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hyun-Chul Chung, Ye-Ji Kim, Eun-Ji Chun, Sang-Seok Kim, Chul-Woo Kim
{"title":"Hands and Wrists Are the Best Sites for Diagnosing Scabies Through Dermoscopy and Microscopy.","authors":"Hyun-Chul Chung, Ye-Ji Kim, Eun-Ji Chun, Sang-Seok Kim, Chul-Woo Kim","doi":"10.5021/ad.23.101","DOIUrl":"10.5021/ad.23.101","url":null,"abstract":"","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"37 1","pages":"46-48"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Seung-Won Jung, Long-Quan Pi, Jae Joon Jeon, You Hyun Kim, Solam Lee, Won-Soo Lee
Background: Oxidative stress causes fatal damage to follicular keratinocytes (FKCs) and is a common pathophysiology of many hair disorders.
Objective: This study investigated the protective effects of Red ginseng extract (RGE) and its main ginsenosides against oxidative hair damage using an in vitro organ model of human hair follicles.
Methods: We examined whether RGE and its constituent ginsenosides could prevent oxidative damage induced by H₂O₂ in FKCs by suppressing apoptosis and promoting hair growth.
Results: RGE and its main ginsenoside, G-Rb1, significantly inhibited reactive oxygen species production and apoptosis in FKCs. Furthermore, they effectively alleviated the inhibition of hair growth induced by oxidative damage and inhibited the transition of hair from the anagen to the telogen stage. The hair cycle and apoptosis were associated with the modulation of p53 and Bax/Bcl2 signaling.
Conclusion: RGE and G-Rb1 can effectively mitigate the oxidative damage caused by FKCs, thereby affecting hair growth and hair cycles.
{"title":"Protective Effects of Korean Red Ginseng Against Oxidative Stress-Induced Damage in Human Hair.","authors":"Seung-Won Jung, Long-Quan Pi, Jae Joon Jeon, You Hyun Kim, Solam Lee, Won-Soo Lee","doi":"10.5021/ad.24.047","DOIUrl":"10.5021/ad.24.047","url":null,"abstract":"<p><strong>Background: </strong>Oxidative stress causes fatal damage to follicular keratinocytes (FKCs) and is a common pathophysiology of many hair disorders.</p><p><strong>Objective: </strong>This study investigated the protective effects of Red ginseng extract (RGE) and its main ginsenosides against oxidative hair damage using an <i>in vitro</i> organ model of human hair follicles.</p><p><strong>Methods: </strong>We examined whether RGE and its constituent ginsenosides could prevent oxidative damage induced by H₂O₂ in FKCs by suppressing apoptosis and promoting hair growth.</p><p><strong>Results: </strong>RGE and its main ginsenoside, G-Rb1, significantly inhibited reactive oxygen species production and apoptosis in FKCs. Furthermore, they effectively alleviated the inhibition of hair growth induced by oxidative damage and inhibited the transition of hair from the anagen to the telogen stage. The hair cycle and apoptosis were associated with the modulation of p53 and Bax/Bcl2 signaling.</p><p><strong>Conclusion: </strong>RGE and G-Rb1 can effectively mitigate the oxidative damage caused by FKCs, thereby affecting hair growth and hair cycles.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"37 1","pages":"1-11"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Age Below 40 Years Is Associated With Human Papillomavirus Vaccination Success for Recalcitrant Warts.","authors":"Sooyun Park, Hyun-Sun Yoon","doi":"10.5021/ad.24.061","DOIUrl":"10.5021/ad.24.061","url":null,"abstract":"","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"37 1","pages":"49-51"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heeyeon Kim, Sejin Oh, Hyungrye Noh, Byeonghyun Joo, Joonho Shim, Jihye Park, Dongyoun Lee, Jong Hee Lee
Background: There is a growing demand for extending dosing intervals of dupilumab injections in patients with atopic dermatitis (AD) due to treatment burden and side effects. However, studies on successful dose reduction in real-world settings are lacking.
Objective: To assess the efficacy of a patient-centered dupilumab tapering regimen and to propose guidelines for target patients, appropriate intervals, and timing for tapering.
Methods: This single-center retrospective study included moderate to severe adult AD patients who underwent at least 16 weeks of dupilumab treatment. Interval prolongation was considered in controlled patients assessed by Eczema Area and Severity Index (EASI) score and serum inflammatory markers after at least 40 weeks of treatment with a standard regimen. Logistic regression model with generalized estimating equations was used to compare repetitive measurements over time between the two groups.
Results: A total of 52 patients were included with 11 patients extending intervals to 3-4 weeks without flare-ups. The mean duration of dupilumab treatment before tapering was 53.27 weeks. The tapering group exhibited significantly lower body mass index. All patients of the tapering group showed EASI scores under 4 and immunoglobulin E (IgE) levels under 1,000 IU/mL at week 40. EASI scores and IgE levels remained consistently low after dose reduction, with a mean follow-up time of 14.36 months.
Conclusion: Patients with extended dosing intervals demonstrated sustained effectiveness. Dose tapering might be a valuable option for non-obese patients with positive clinical response characterized by an EASI score under 4 and IgE levels under 1,000 at week 40.
{"title":"Appropriate Injection Intervals of Dupilumab in Patients With Adult Atopic Dermatitis: A Step Toward Developing Guidelines for Daily Practice.","authors":"Heeyeon Kim, Sejin Oh, Hyungrye Noh, Byeonghyun Joo, Joonho Shim, Jihye Park, Dongyoun Lee, Jong Hee Lee","doi":"10.5021/ad.24.084","DOIUrl":"10.5021/ad.24.084","url":null,"abstract":"<p><strong>Background: </strong>There is a growing demand for extending dosing intervals of dupilumab injections in patients with atopic dermatitis (AD) due to treatment burden and side effects. However, studies on successful dose reduction in real-world settings are lacking.</p><p><strong>Objective: </strong>To assess the efficacy of a patient-centered dupilumab tapering regimen and to propose guidelines for target patients, appropriate intervals, and timing for tapering.</p><p><strong>Methods: </strong>This single-center retrospective study included moderate to severe adult AD patients who underwent at least 16 weeks of dupilumab treatment. Interval prolongation was considered in controlled patients assessed by Eczema Area and Severity Index (EASI) score and serum inflammatory markers after at least 40 weeks of treatment with a standard regimen. Logistic regression model with generalized estimating equations was used to compare repetitive measurements over time between the two groups.</p><p><strong>Results: </strong>A total of 52 patients were included with 11 patients extending intervals to 3-4 weeks without flare-ups. The mean duration of dupilumab treatment before tapering was 53.27 weeks. The tapering group exhibited significantly lower body mass index. All patients of the tapering group showed EASI scores under 4 and immunoglobulin E (IgE) levels under 1,000 IU/mL at week 40. EASI scores and IgE levels remained consistently low after dose reduction, with a mean follow-up time of 14.36 months.</p><p><strong>Conclusion: </strong>Patients with extended dosing intervals demonstrated sustained effectiveness. Dose tapering might be a valuable option for non-obese patients with positive clinical response characterized by an EASI score under 4 and IgE levels under 1,000 at week 40.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"37 1","pages":"39-45"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791021/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Although nail psoriasis is a common manifestation among patients with psoriasis, large-scale research exploring the association between nail psoriasis lesions and their intra-nail locations has not been conducted. This study is necessary to elucidate the shared pathophysiology among various phenotypes of nail psoriasis.
Objective: We aimed to understand the association between nail psoriasis lesions and analyze their intra-nail locations.
Methods: We obtained a total of 5,602 cropped fingernail images from 636 patients with psoriasis. We employed the Computer Vision Annotation Tool to annotate the intra-nail locations of nail psoriasis lesions. We computed χ² statistic to examine the relationship between nail psoriasis lesions and conducted an analysis of their intra-nail locations.
Results: Based on the number of lesions, nail pitting was the most common, followed by leukonychia, with the red spots in the lunula being the rarest. We elucidated the associations between different nail psoriasis lesions, pinpointing a significant association between onycholysis and oil spots (χ² statistic=1,623.88), followed by onycholysis-subungual hyperkeratosis (1,607.50), and subungual hyperkeratosis-oil spots (985.76). A spatial relationship was observed between onycholysis and oil spots, with the intra-nail location of onycholysis being more distal compared to the nearest oil spots. A distribution pattern of nail psoriasis was also demonstrated, where nail matrix lesions were primarily located at the center of the nail, and nail bed lesions were predominantly located near the lateral nail folds.
Conclusion: This study represents a pioneering analysis of the intra-nail location of nail psoriasis lesions, revealing substantial associations and spatial relationships between different lesions.
{"title":"Analysis of the Intra-Nail Location of Nail Psoriasis.","authors":"Kyungho Paik, Bo Ri Kim, Sang Woong Youn","doi":"10.5021/ad.24.075","DOIUrl":"10.5021/ad.24.075","url":null,"abstract":"<p><strong>Background: </strong>Although nail psoriasis is a common manifestation among patients with psoriasis, large-scale research exploring the association between nail psoriasis lesions and their intra-nail locations has not been conducted. This study is necessary to elucidate the shared pathophysiology among various phenotypes of nail psoriasis.</p><p><strong>Objective: </strong>We aimed to understand the association between nail psoriasis lesions and analyze their intra-nail locations.</p><p><strong>Methods: </strong>We obtained a total of 5,602 cropped fingernail images from 636 patients with psoriasis. We employed the Computer Vision Annotation Tool to annotate the intra-nail locations of nail psoriasis lesions. We computed χ² statistic to examine the relationship between nail psoriasis lesions and conducted an analysis of their intra-nail locations.</p><p><strong>Results: </strong>Based on the number of lesions, nail pitting was the most common, followed by leukonychia, with the red spots in the lunula being the rarest. We elucidated the associations between different nail psoriasis lesions, pinpointing a significant association between onycholysis and oil spots (χ² statistic=1,623.88), followed by onycholysis-subungual hyperkeratosis (1,607.50), and subungual hyperkeratosis-oil spots (985.76). A spatial relationship was observed between onycholysis and oil spots, with the intra-nail location of onycholysis being more distal compared to the nearest oil spots. A distribution pattern of nail psoriasis was also demonstrated, where nail matrix lesions were primarily located at the center of the nail, and nail bed lesions were predominantly located near the lateral nail folds.</p><p><strong>Conclusion: </strong>This study represents a pioneering analysis of the intra-nail location of nail psoriasis lesions, revealing substantial associations and spatial relationships between different lesions.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"37 1","pages":"32-38"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11791025/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ji-In Seo, Hasung Kim, Jung Kuk Lee, Hye-Jin Ahn, Ki-Heon Jeong, Min Kyung Shin
{"title":"Increased Risk of Superficial Fungal Infections Among Psoriasis Patients Receiving Systemic Treatment: A Nationwide Retrospective Population-Based Cohort Study.","authors":"Ji-In Seo, Hasung Kim, Jung Kuk Lee, Hye-Jin Ahn, Ki-Heon Jeong, Min Kyung Shin","doi":"10.5021/ad.24.027","DOIUrl":"10.5021/ad.24.027","url":null,"abstract":"","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"36 6","pages":"395-397"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hui Young Shin, Yu Jeong Park, Woo Kyoung Choi, Hyun Bo Sim, Seung Ho Lee, Ai Young Lee, Jong Soo Hong
Background: Various treatment modalities are used to treat keloids. However, a comprehensive assessment comparing the effectiveness of these modalities in terms of patient-reported outcomes is warranted.
Objective: To assess and compare the effectiveness of various treatment modalities for keloids.
Methods: We assessed treatment outcomes in a cohort of 250 patients diagnosed with keloids. The patients were categorized into four treatment groups: triamcinolone acetonide (TA), TA + cryotherapy, TA + pulsed dye laser (PDL), and TA + cryotherapy + PDL. The Vancouver Scar Scale was used to evaluate the keloid severity before and after treatment.
Results: Significant differences were noted in the Vancouver Scale scores among the treatment groups (p=0.023). Notably, the TA + cryotherapy + PDL group exhibited the most substantial improvement in the Vancouver Scale scores, whereas the TA + PDL group showed the least difference. Pliability was the most significantly improved in the TA + cryotherapy + PDL group (p=0.039). Male patients experienced a greater reduction in pigmentation scores than female patients (p=0.037).
Conclusion: Our findings highlight the effectiveness of combined therapies, particularly TA + cryotherapy + PDL, in improving keloid-related parameters. These results offer valuable insights for clinicians in tailoring keloid treatment strategies and support the implementation of combination therapies for enhanced outcomes. This study underscores the importance of comprehensively assessing treatment modalities for keloid management. Combination therapies such as TA + cryotherapy + PDL irradiation have demonstrated significant promise in improving keloid characteristics.
{"title":"Assessment of Treatment Modalities in Patients With Keloids: A Vancouver Scale Comparison.","authors":"Hui Young Shin, Yu Jeong Park, Woo Kyoung Choi, Hyun Bo Sim, Seung Ho Lee, Ai Young Lee, Jong Soo Hong","doi":"10.5021/ad.23.160","DOIUrl":"10.5021/ad.23.160","url":null,"abstract":"<p><strong>Background: </strong>Various treatment modalities are used to treat keloids. However, a comprehensive assessment comparing the effectiveness of these modalities in terms of patient-reported outcomes is warranted.</p><p><strong>Objective: </strong>To assess and compare the effectiveness of various treatment modalities for keloids.</p><p><strong>Methods: </strong>We assessed treatment outcomes in a cohort of 250 patients diagnosed with keloids. The patients were categorized into four treatment groups: triamcinolone acetonide (TA), TA + cryotherapy, TA + pulsed dye laser (PDL), and TA + cryotherapy + PDL. The Vancouver Scar Scale was used to evaluate the keloid severity before and after treatment.</p><p><strong>Results: </strong>Significant differences were noted in the Vancouver Scale scores among the treatment groups (<i>p</i>=0.023). Notably, the TA + cryotherapy + PDL group exhibited the most substantial improvement in the Vancouver Scale scores, whereas the TA + PDL group showed the least difference. Pliability was the most significantly improved in the TA + cryotherapy + PDL group (<i>p</i>=0.039). Male patients experienced a greater reduction in pigmentation scores than female patients (<i>p</i>=0.037).</p><p><strong>Conclusion: </strong>Our findings highlight the effectiveness of combined therapies, particularly TA + cryotherapy + PDL, in improving keloid-related parameters. These results offer valuable insights for clinicians in tailoring keloid treatment strategies and support the implementation of combination therapies for enhanced outcomes. This study underscores the importance of comprehensively assessing treatment modalities for keloid management. Combination therapies such as TA + cryotherapy + PDL irradiation have demonstrated significant promise in improving keloid characteristics.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"36 6","pages":"348-354"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621645/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jung Eun Kim, Subin Lee, Hoon Kang, Young Lee, Do-Young Kim, Hyunsun Park, Hyun-Tae Shin, Yong Hyun Jang, Kihyuk Shin, Ji Hae Lee, Jee Woong Choi, Byung Choel Park, Beom Joon Kim, Soo Hong Seo, Chong Hyun Won, Jin Park, Min Sung Kim, Sang Seok Kim, Bark-Lynn Lew, Chang-Hun Huh, Ohsang Kwon, Yang Won Lee, Moon-Bum Kim
Background: Alopecia areata (AA) is characterized by hair loss on the scalp and body, significantly impacting patients' quality of life based on its severity.
Objective: This study aims to identify crucial factors influencing the perception of severe AA from the patients' viewpoint.
Methods: A web-based survey was conducted among AA patients attending dermatology departments at 21 university hospitals in Korea. The survey comprised 17 criteria, exploring both clinical characteristics of AA patients and subjective determinants of disease severity.
Results: A total of 791 AA patients and their caregivers participated in the survey. Approximately 30% of respondents developed AA during childhood, with 43.5% experiencing chronic courses lasting over 3 years. Half of the participants exhibited more than 20% scalp hair loss, and 42% reported additional hair loss on other body parts, such as eyelashes and nose hair. Most respondents agreed that patients with ≥20% scalp hair loss should be categorized as having severe AA. They also identified longer disease duration, involvement of non-scalp body hair, treatment refractoriness, and social or mental impairment requiring medical intervention as factors indicating increased disease severity.
Conclusion: This survey underscores the significant impact of AA on patients' quality of life and highlights existing unmet needs in current treatment modalities.
{"title":"Survey on Alopecia Areata Patients' Reported Factors that Determine Severity of Alopecia Areata: A Nationwide Multicenter Study.","authors":"Jung Eun Kim, Subin Lee, Hoon Kang, Young Lee, Do-Young Kim, Hyunsun Park, Hyun-Tae Shin, Yong Hyun Jang, Kihyuk Shin, Ji Hae Lee, Jee Woong Choi, Byung Choel Park, Beom Joon Kim, Soo Hong Seo, Chong Hyun Won, Jin Park, Min Sung Kim, Sang Seok Kim, Bark-Lynn Lew, Chang-Hun Huh, Ohsang Kwon, Yang Won Lee, Moon-Bum Kim","doi":"10.5021/ad.24.033","DOIUrl":"10.5021/ad.24.033","url":null,"abstract":"<p><strong>Background: </strong>Alopecia areata (AA) is characterized by hair loss on the scalp and body, significantly impacting patients' quality of life based on its severity.</p><p><strong>Objective: </strong>This study aims to identify crucial factors influencing the perception of severe AA from the patients' viewpoint.</p><p><strong>Methods: </strong>A web-based survey was conducted among AA patients attending dermatology departments at 21 university hospitals in Korea. The survey comprised 17 criteria, exploring both clinical characteristics of AA patients and subjective determinants of disease severity.</p><p><strong>Results: </strong>A total of 791 AA patients and their caregivers participated in the survey. Approximately 30% of respondents developed AA during childhood, with 43.5% experiencing chronic courses lasting over 3 years. Half of the participants exhibited more than 20% scalp hair loss, and 42% reported additional hair loss on other body parts, such as eyelashes and nose hair. Most respondents agreed that patients with ≥20% scalp hair loss should be categorized as having severe AA. They also identified longer disease duration, involvement of non-scalp body hair, treatment refractoriness, and social or mental impairment requiring medical intervention as factors indicating increased disease severity.</p><p><strong>Conclusion: </strong>This survey underscores the significant impact of AA on patients' quality of life and highlights existing unmet needs in current treatment modalities.</p>","PeriodicalId":94298,"journal":{"name":"Annals of dermatology","volume":"36 6","pages":"376-383"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11621644/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142776243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}